Morgan Stanley Purple Biotech Ltd. Transaction History

Morgan Stanley

  • $1.35 Trillion
  • Q3 2024

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Oct 17, 2024
BUY
$0.41 - $0.86 $27,219 - $57,095
66,390 Added 48.6%
203,000 $83,000
Q2 2024

Aug 14, 2024
BUY
$0.41 - $0.86 $27,219 - $57,095
66,390 Added 48.6%
203,000 $83,000
Q1 2024

Oct 17, 2024
SELL
$0.58 - $0.92 $38,506 - $61,078
-66,390 Reduced 32.7%
136,610 $91,000
Q1 2024

Aug 16, 2024
BUY
$0.58 - $0.92 $29,056 - $46,089
50,097 Added 57.91%
136,610 $91,000
Q1 2024

May 15, 2024
BUY
$0.58 - $0.92 $29,056 - $46,089
50,097 Added 57.91%
136,610 $91,000
Q4 2023

Aug 16, 2024
SELL
$0.78 - $1.67 $90,859 - $194,533
-116,487 Reduced 57.38%
86,513 $67,000
Q4 2023

Feb 13, 2024
BUY
$0.78 - $1.67 $43,768 - $93,708
56,113 Added 184.58%
86,513 $67,000
Q3 2023

Nov 15, 2023
BUY
$1.02 - $1.49 $783 - $1,144
768 Added 2.59%
30,400 $36,000
Q2 2023

Aug 14, 2023
BUY
$1.38 - $2.05 $9,030 - $13,415
6,544 Added 28.34%
29,632 $41,000
Q1 2023

May 15, 2023
BUY
$1.36 - $2.3 $1,656 - $2,801
1,218 Added 5.57%
23,088 $41,000
Q4 2022

Feb 14, 2023
BUY
$1.38 - $2.22 $7,727 - $12,432
5,600 Added 34.42%
21,870 $30,000
Q3 2022

Nov 14, 2022
SELL
$1.9 - $2.69 $950 - $1,345
-500 Reduced 2.98%
16,270 $33,000
Q2 2022

Oct 27, 2022
BUY
$2.39 - $4.15 $21,359 - $37,088
8,937 Added 114.09%
16,770 $40,000
Q2 2022

Aug 15, 2022
BUY
$2.39 - $4.15 $21,359 - $37,088
8,937 Added 114.09%
16,770 $40,000
Q1 2022

Oct 27, 2022
SELL
$2.45 - $4.3 $21,895 - $38,429
-8,937 Reduced 53.29%
7,833 $31,000
Q1 2022

May 13, 2022
SELL
$2.45 - $4.3 $38,202 - $67,049
-15,593 Reduced 66.56%
7,833 $31,000
Q4 2021

Feb 14, 2022
SELL
$3.75 - $4.67 $502 - $625
-134 Reduced 0.57%
23,426 $91,000
Q3 2021

Nov 15, 2021
BUY
$4.4 - $5.59 $103,664 - $131,700
23,560 New
23,560 $108,000

Others Institutions Holding PPBT

# of Institutions
1
Shares Held
15
Call Options Held
0
Put Options Held
0
View Full List

About PURPLE BIOTECH LTD.

PPBT Quotes by TradingView
  • Ticker PPBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,303,300
  • Market Cap $67M
  • Description
  • Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhi...
More about PPBT
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email